Biography:
Xiangbing Wang graduated from Hunan Medical University in and received his BS degree in 1983 and finished clinical Endocrine fellowship training in China, 1986. He obtained his Ph.D. in the fields of Physiology/Pharmacology from Oregon Health Science University, USA in 1994 and finished his postgraduate training in the field of Endocrine Pharmacology at Yale University in 1996. He completed his 5-year clinical training in Internal Medicine and Endocrinology at Interfaith Medical Center, SUNY in 2001. Currently, he is a Professor of Medicine and director of a research laboratory for metabolic disorders at Rutgers University-RWJ Medical School. He is an experienced clinical endocrinologist, a principal investigator of several clinical trials and a Top Doctor of New Jersey 2017. He is a member of the publication and clinical research committees of the American Association of Clinical Endocrinologists. He serves on the editorial boards of several peer-reviewed journals, including Endocrine Practice, and he has published more than 100 research articles in several medical journals including NJEM, JCEM, Endocrinology, Metabolism, and Neuroendocrinology. For the last 20 years, his clinical research has focused on vitamin D binding protein, primary hyperparathyroidism, and cardiovascular risk factors. Google citation about 5800. .
Clinical Interests:
Adult general endocrinologist with special interesting in hyperparathyroidism, vitamin D deficiency and Autoimmune diabetes.
Research Interests and clinical projects:
Vitamin D, vitamin D binding protein and Parathyroid disorders.